Skip to content
Brasil Peru Mexico

 

  • ABRASCÃO 2025 Substance Use and Adherence to Oral PrEP Among MSM, Transvestites, and Transgender Women in Latin America: Results from the ImPrEP Study

  • ABRASCÃO 2025 Mental health and substance use among young people from sexual and gender minorities: findings from the ImPrEP CAB Brazil study

  • ABRASCÃO 2025 ImPrEP CAB Brazil: Analyzing PrEP Choices and Increasing Coverage of Prophylaxis with Injectable Cabotegravir in Key Young Populations

  • High syphilis incidence among PrEP – adherent men who have sex with men and transgender women in Peru

Imprep
Rio de Janeiro: Fundação Oswaldo Cruz – Fiocruz Av. Brasil, 4365 - Rio de Janeiro
9090 (21) 2260-6700 e (21) 3865-9659
imprep.bra@gmail.com
  • Home
  • What is PrEP?
  • IMPREP project
  • Sites that provide PrEP
  • Studies and Research
    • Presentations at Conferences
    • Published Articles

Category: Information

Studies and Researches

Costs of implementing long-acting injectable cabotegravir as HIV prophylaxis in Brazil

Article by ImPrEP published at Physis in2023, September https://doi.org/10.1590/S0103-7331202333021

18 de July de 2024
Studies and Researches

Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study

Article by ImPrEP published at Therapeutic Advances in Infectious Disease in 2023, February https://doi.org/10.1177/20499361231153548

18 de July de 2024
Studies and Researches

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Article by ImPrEP published at JMIR Public Health and Surveillance in 2023, April http://dx.doi.org/10.2196/44961

18 de July de 2024
Studies and Researches

Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study

Article by ImPrEP published at The Lancet HIV in 2022, December https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00331-9/fulltext

18 de July de 2024
Studies and Researches

Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey

Article by ImPrEP published at BMC Health in 2022, April https://link.springer.com/article/10.1186/s12913-022-07900-y

18 de July de 2024
Studies and Researches

Barriers and facilitators for access to PrEP by vulnerable populations in Brazil: the ImPrEP Stakeholders Study

Article by ImPrEP published at Cadernos de Saúde Pública in 2022, January http://dx.doi.org/10.1590/0102-311X00290620

18 de July de 2024
Studies and Researches

High Rates of Sexualized Drug Use or Chemsex among Brazilian Transgender Women and Young Sexual and Gender Minorities

Article by ImPrEP published at International Journal of Environmental Research and Public Health in 2022, February https://www.mdpi.com/1660-4601/19/3/1704/html

18 de July de 2024
Studies and Researches

Awareness, willingness and barriers to HIV Self-testing (HIVST) among Men who Have Sex with Men (MSM) in Brazil, Mexico, and Peru: A web-based cross-sectional study

Article by ImPrEP published at Plos Global Public Health in 2022, July https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000678

18 de July de 2024
Studies and Researches

HIV Risk Perception and Pre-Exposure Prophylaxis (PrEP) Awareness Among Transgender Women from Mexico

Article by ImPrEP published at AIDS and Behavior in 2022, September https://link.springer.com/article/10.1007/s10461-022-03836-w

18 de July de 2024
Studies and Researches

Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study

Article by ImPrEP published in Journal of International AIDS Society in 2022, October https://onlinelibrary.wiley.com/doi/10.1002/jia2.25974

18 de July de 202418 de July de 2024

Posts navigation

Older posts
Newer posts

Partners

UnitAid INI - Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde do Brasil UnitAid Universidad Peruana Cayetano Heredia Instituto Nacional de Salud Pública CONDESA Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde - Brasil
Theme of Rigorous Themes